Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Primer
  • Published:

Differences of sex development

Abstract

Differences of sex development (DSD) represent a group of congenital conditions that affect human sex development and maturation owing to discrepancies of chromosomal, gonadal and phenotypic sex. The Chicago consensus classifies DSD as sex chromosome DSD, 46,XY DSD and 46,XX DSD, with subclassifications according to gonadal determination into testes and ovaries and hormone-dependent differentiation of Müllerian and Wolffian embryonic structures into female-typical or male-typical internal and external sex organs. DSD may occur as an isolated condition or as part of a complex syndrome. Diagnosis is based on clinical characteristics, imaging studies, hormonal measurements and genetic investigations. Management includes lifelong psychosocial support, hormonal treatments and surgical interventions that require personalization for each case as DSD encompasses a wide variety of aetiologies and presentations. This personalization must also consider individual values and preferences to ensure that clinical care is tailored to meet the unique needs and circumstances of each person, ideally provided by a care team with diverse specialities. This care involves psycho-educational counselling on the condition and its consequences, considering family and cultural norms. Additional efforts are needed to bridge gaps in knowledge related to diagnosis, management and long-term outcomes. Enhancing our understanding of the distinctions between sex and gender in societies is essential as greater awareness will inform and enrich public debates.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Classification of DSD based on karyotype and diagnostic category leading to a specific diagnosis.
Fig. 2: Associated organ anomalies and comorbidities of DSD.
Fig. 3: Sex determination of the human ovaries and testes from the bipotential gonads at 4–16 weeks of gestation.
Fig. 4: Sex differentiation.
Fig. 5: 46,XX ovotesticular DSD.
Fig. 6: Sex steroid hormone biosynthesis and associated DSD.
Fig. 7: Diagnostic algorithm for 46,XY DSD with atypical genitalia at birth.
Fig. 8: Diagnostic algorithm for 46,XX DSD.
Fig. 9: Development of GCTs in DSD and their proposed management.
Fig. 10: Multidisciplinary care at diagnosis and across the lifespan.
Fig. 11: Schematic representation of a risk stratification model and recommendations for clinical follow-up.
Fig. 12: Research priorities in DSD: insights from data requests, health-care providers and patient perspectives.

Similar content being viewed by others

References

  1. Melmed, S., Koenig, R., Rosen, C. J., Auchus, R. J. & Goldfine, A. B. Williams Textbook of Endocrinology (Elsevier, 2019).

  2. Cools, M. et al. Caring for individuals with a difference of sex development (DSD): a consensus statement. Nat. Rev. Endocrinol. 14, 415–429 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hughes, I. A., Houk, C., Ahmed, S. F. & Lee, P. A. Lawson Wilkins pediatric endocrine society/European society for paediatric endocrinology consensus g. consensus statement on management of intersex disorders. J. Pediatr. Urol. 2, 148–162 (2006).

    Article  CAS  PubMed  Google Scholar 

  4. Lee, P. A. et al. Global disorders of sex development update since 2006: perceptions, approach and care. Horm. Res. Paediatr. 85, 158–180 (2016).

    Article  CAS  PubMed  Google Scholar 

  5. Kouri, C. et al. Clinical and genetic characteristics of a large international cohort of individuals with rare NR5A1/SF-1 variants of sex development. eBioMedicine 99, 104941 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Division of Family and Reproductive Health. Gender and Health: Technical Paper (World Health Organization, 1998).

  7. Claahsen-van der Grinten, H. L. et al. Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr. Rev. 43, 91–159 (2022).

    Article  PubMed  Google Scholar 

  8. Gravholt, C. H. et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati international turner syndrome meeting. Eur. J. Endocrinol. 177, G1–G70 (2017).

    Article  CAS  PubMed  Google Scholar 

  9. Gravholt, C. H. et al. New developments and future trajectories in supernumerary sex chromosome abnormalities: a summary of the 2022 3rd International workshop on klinefelter syndrome, Trisomy X, and XYY. Endocr. Connect. 12, e220500 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Gravholt, C. H., Viuff, M. H., Brun, S., Stochholm, K. & Andersen, N. H. Turner syndrome: mechanisms and management. Nat. Rev. Endocrinol. 15, 601–614 (2019).

    Article  PubMed  Google Scholar 

  11. Kanakatti Shankar, R., Gravholt, C. H. & Backeljauw, P. F. Evolution of health care in turner syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 199, e32124 (2024).

    Article  PubMed  Google Scholar 

  12. Zitzmann, M. et al. European Academy of Andrology guidelines on Klinefelter syndrome endorsing organization: European Society of Endocrinology. Andrology 9, 145–167 (2021).

    Article  CAS  PubMed  Google Scholar 

  13. Speiser, P. W. et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103, 4043–4088 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shankar, R. K. & Backeljauw, P. F. Current best practice in the management of Turner syndrome. Ther. Adv. Endocrinol. Metab. 9, 33–40 (2018).

    Article  PubMed  Google Scholar 

  15. Merke, D. P. & Auchus, R. J. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 383, 1248–1261 (2020).

    Article  CAS  PubMed  Google Scholar 

  16. Ratcliffe, S. Long-term outcome in children of sex chromosome abnormalities. Arch. Dis. Child. 80, 192–195 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhao, Y. et al. Detection and characterization of male sex chromosome abnormalities in the UK biobank study. Genet. Med. 24, 1909–1919 (2022).

    Article  CAS  PubMed  Google Scholar 

  18. Jacobs, P. A., Melville, M., Ratcliffe, S., Keay, A. J. & Syme, J. A cytogenetic survey of 11,680 newborn infants. Ann. Hum. Genet. 37, 359–376 (1974).

    Article  CAS  PubMed  Google Scholar 

  19. Nielsen, J. & Wohlert, M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum. Genet. 87, 81–83 (1991).

    Article  CAS  PubMed  Google Scholar 

  20. Lucas-Herald, A. K. et al. The outcome of prenatal identification of sex chromosome abnormalities. Arch. Dis. Child. Fetal Neonatal Ed. 101, F423–F427 (2016).

    Article  PubMed  Google Scholar 

  21. Ahmed, S. F. et al. Prevalence of hypospadias and other genital anomalies among singleton births, 1988-1997, in Scotland. Arch. Dis. Child. Fetal Neonatal Ed. 89, F149–F151 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rodie, M. E. et al. A nationwide study of the prevalence and initial management of atypical genitalia in the newborn in Scotland. Sex. Dev. 16, 11–18 (2022).

    Article  PubMed  Google Scholar 

  23. Acerini, C. L., Miles, H. L., Dunger, D. B., Ong, K. K. & Hughes, I. A. The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort. Arch. Dis. Child. 94, 868–872 (2009).

    Article  CAS  PubMed  Google Scholar 

  24. Virtanen, H. E. & Toppari, J. Epidemiology and pathogenesis of cryptorchidism. Hum. Reprod. Update 14, 49–58 (2008).

    Article  CAS  PubMed  Google Scholar 

  25. Nixon, R. et al. Prevalence of endocrine and genetic abnormalities in boys evaluated systematically for a disorder of sex development. Hum. Reprod. 32, 2130–2137 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tang, Y. et al. Clinical characteristics and genetic expansion of 46,XY disorders of sex development children in a Chinese prospective study. Endocr. Connect. 12, e230029 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gazdagh, G., Tobias, E. S., Ahmed, S. F. & McGowan, R.; DDD Study Group. Novel genetic associations and range of phenotypes in children with disorders of sex development and neurodevelopment: insights from the deciphering developmental disorders study. Sex. Dev. 10, 130–135 (2016).

    Article  CAS  PubMed  Google Scholar 

  28. Cox, K. et al. Novel associations in disorders of sex development: findings from the I-DSD registry. J. Clin. Endocrinol. Metab. 99, E348–E355 (2014).

    Article  CAS  PubMed  Google Scholar 

  29. Ahmed, S. F. et al. Society for endocrinology UK guidance on the initial evaluation of a suspected difference or disorder of sex development (Revised 2021). Clin. Endocrinol. 95, 818–840 (2021).

    Article  Google Scholar 

  30. Berglund, A. et al. Incidence, prevalence, diagnostic delay, and clinical presentation of female 46,XY disorders of sex development. J. Clin. Endocrinol. Metab. 101, 4532–4540 (2016).

    Article  CAS  PubMed  Google Scholar 

  31. Batista, R. L. et al. Androgen insensitivity syndrome: a review. Arch. Endocrinol. Metab. 62, 227–235 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  32. Callens, N. et al. Sexual quality of life after hormonal and surgical treatment, including phalloplasty, in men with micropenis: a review. J. Sex. Med. 10, 2890–2903 (2013).

    Article  PubMed  Google Scholar 

  33. Lucas-Herald, A. et al. The long-term outcome of boys with partial androgen insensitivity syndrome and a mutation in the androgen receptor gene. J. Clin. Endocrinol. Metab. 101, 3959–3967 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Falhammar, H. et al. Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study. Endocr. Connect. 7, 466–478 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Lucas-Herald, A. K. et al. Vascular dysfunction and increased cardiovascular risk in hypospadias. Eur. Heart J. 43, 1832–1845 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Phillips, L. et al. Increased androgen-related comorbidity in adolescents and adults born with hypospadias: a population-based study. Andrology 10, 1376–1386 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Reyes, A. P., Leon, N. Y., Frost, E. R. & Harley, V. R. Genetic control of typical and atypical sex development. Nat. Rev. Urol. 20, 434–451 (2023).

    Article  PubMed  Google Scholar 

  38. Rotgers, E., Jorgensen, A. & Yao, H. H. At the crossroads of fate-somatic cell lineage specification in the fetal gonad. Endocr. Rev. 39, 739–759 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Stevant, I. & Nef, S. Genetic control of gonadal sex determination and development. Trends Genet. 35, 346–358 (2019).

    Article  CAS  PubMed  Google Scholar 

  40. Nef, S., Stevant, I. & Greenfield, A. Characterizing the bipotential mammalian gonad. Curr. Top. Dev. Biol. 134, 167–194 (2019).

    Article  CAS  PubMed  Google Scholar 

  41. Garcia-Alonso, L. et al. Single-cell roadmap of human gonadal development. Nature 607, 540–547 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Croft, B. et al. Human sex reversal is caused by duplication or deletion of core enhancers upstream of SOX9. Nat. Commun. 9, 5319 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Vining, B., Ming, Z., Bagheri-Fam, S. & Harley, V. Diverse regulation but conserved function: SOX9 in vertebrate sex determination. Genes 12, 486 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Ming, Z., Vining, B., Bagheri-Fam, S. & Harley, V. SOX9 in organogenesis: shared and unique transcriptional functions. Cell Mol. Life Sci. 79, 522 (2022).

    Article  CAS  PubMed  Google Scholar 

  45. Sreenivasan, R., Gonen, N. & Sinclair, A. SOX genes and their role in disorders of sex development. Sex. Dev. 16, 80–91 (2022).

    Article  CAS  PubMed  Google Scholar 

  46. Leon, N. Y. & Harley, V. R. ATR-X syndrome: genetics, clinical spectrum, and management. Hum. Genet. 140, 1625–1634 (2021).

    Article  PubMed  Google Scholar 

  47. Biason-Lauber, A. & Chaboissier, M. C. Ovarian development and disease: the known and the unexpected. Semin. Cell Dev. Biol. 45, 59–67 (2015).

    Article  CAS  PubMed  Google Scholar 

  48. He, J. et al. Unveiling the role of FOXL2 in female differentiation and disease: a comprehensive reviewdagger. Biol. Reprod. 112, 600–613 (2025).

    Article  CAS  PubMed  Google Scholar 

  49. Barbaux, S. et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17, 467–470 (1997).

    Article  CAS  PubMed  Google Scholar 

  50. Bradford, S. T. et al. A cell-autonomous role for WT1 in regulating Sry in vivo. Hum. Mol. Genet. 18, 3429–3438 (2009).

    Article  CAS  PubMed  Google Scholar 

  51. Elzaiat, M., McElreavey, K. & Bashamboo, A. Genetics of 46,XY gonadal dysgenesis. Best Pract. Res. Clin. Endocrinol. Metab. 36, 101633 (2022).

    Article  CAS  PubMed  Google Scholar 

  52. McCann-Crosby, B. et al. State of the art review in gonadal dysgenesis: challenges in diagnosis and management. Int. J. Pediatr. Endocrinol. 2014, 4 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  53. Sreenivasan, R. et al. Mutant NR5A1/SF-1 in patients with disorders of sex development shows defective activation of the SOX9 TESCO enhancer. Hum. Mutat. 39, 1861–1874 (2018).

    Article  CAS  PubMed  Google Scholar 

  54. Sato, N. S. et al. Partial duplication of DHH causes minifascicular neuropathy: a novel mutation detection of DHH. Ann. Clin. Transl. Neurol. 4, 415–421 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Croft, B. et al. FGF9 variant in 46,XY DSD patient suggests a role for dimerization in sex determination. Clin. Genet. 103, 277–287 (2023).

    Article  CAS  PubMed  Google Scholar 

  56. Bagheri-Fam, S. et al. FGFR2 mutation in 46,XY sex reversal with craniosynostosis. Hum. Mol. Genet. 24, 6699–6710 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Jameson, S. A., Lin, Y. T. & Capel, B. Testis development requires the repression of Wnt4 by Fgf signaling. Dev. Biol. 370, 24–32 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Ferrari, M. T. M. et al. Testicular differentiation in 46,XX DSD: an overview of genetic causes. Front. Endocrinol. 15, 1385901 (2024).

    Article  Google Scholar 

  59. Hiort, M. et al. Testicular architecture of men with 46,XX testicular disorders of sex development. Sex. Dev. 17, 32–42 (2023).

    Article  CAS  PubMed  Google Scholar 

  60. Grinspon, R. P. & Rey, R. A. Disorders of sex development with testicular differentiation in SRY-negative 46,XX individuals: clinical and genetic aspects. Sex. Dev. 10, 1–11 (2016).

    Article  CAS  PubMed  Google Scholar 

  61. Bashamboo, A. et al. Loss of function of the nuclear receptor NR2F2, encoding COUP-TF2, causes testis development and cardiac defects in 46,XX children. Am. J. Hum. Genet. 102, 487–493 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Wankanit, S. et al. Evidence for NR2F2/COUP-TFII involvement in human testis development. Sci. Rep. 14, 17869 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Franca, M. M. & Mendonca, B. B. Genetics of ovarian insufficiency and defects of folliculogenesis. Best Pract. Res. Clin. Endocrinol. Metab. 36, 101594 (2022).

    Article  CAS  PubMed  Google Scholar 

  64. Roly, Z. Y. et al. The cell biology and molecular genetics of Mullerian duct development. Wiley Interdiscip. Rev. Dev. Biol. 7, e310 (2018).

    Article  PubMed  Google Scholar 

  65. Josso, N. & Picard, J. Y. Genetics of anti-Mullerian hormone and its signaling pathway. Best Pract. Res. Clin. Endocrinol. Metab. 36, 101634 (2022).

    Article  CAS  PubMed  Google Scholar 

  66. Josso, N. & Rey, R. A. What does AMH tell us in pediatric disorders of sex development? Front. Endocrinol. 11, 619 (2020).

    Article  Google Scholar 

  67. Connan-Perrot, S. et al. Six decades of research on human fetal gonadal steroids. Int. J. Mol. Sci. 22, 6681 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Miller, W. L. & Auchus, R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81–151 (2011).

    Article  CAS  PubMed  Google Scholar 

  69. Flueck C. E. & Pandey A. V. in Endocrinology of the Testis and Male Reproduction (eds Simoni, M. & Huhtaniemi, I. T.) 1–29 (Springer Cham, 2017).

  70. Favorito, L. A. & Sampaio, F. J. B. in Translational Research in Pediatric Urology Basic and Clinical Aspects (ed. Favorito, L. A.) 27–48 (Springer, 2020).

  71. Favorito, L. A. in Translational Research in Pediatric Urology Basic and Clinical Aspects (ed. Favorito, L. A.) 49–57 (Springer, 2020).

  72. Rey, R. A. Biomarkers of male hypogonadism in childhood and adolescence. Adv. Lab. Med. 1, 20200024 (2020).

    PubMed  PubMed Central  Google Scholar 

  73. Bay, K., Main, K. M., Toppari, J. & Skakkebaek, N. E. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat. Rev. Urol. 8, 187–196 (2011).

    Article  CAS  PubMed  Google Scholar 

  74. Bergada, I. et al. Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J. Clin. Endocrinol. Metab. 91, 4092–4098 (2006).

    Article  CAS  PubMed  Google Scholar 

  75. Busch, A. S. et al. Male minipuberty in human and non-human primates: planting the seeds of future fertility. Reproduction 166, R63–R72 (2023).

    Article  CAS  PubMed  Google Scholar 

  76. Becker, M. & Hesse, V. Minipuberty: why does it happen? Horm. Res. Paediatr. 93, 76–84 (2020).

    Article  CAS  PubMed  Google Scholar 

  77. Johannsen, T. H. et al. Sex differences in reproductive hormones during mini-puberty in infants with normal and disordered sex development. J. Clin. Endocrinol. Metab. 103, 3028–3037 (2018).

    Article  PubMed  Google Scholar 

  78. Aksglaede, L., Davis, S. M., Ross, J. L. & Juul, A. Minipuberty in Klinefelter syndrome: current status and future directions. Am. J. Med. Genet. C. Semin. Med. Genet. 184, 320–326 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  79. Fluck, C. E. et al. Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am. J. Hum. Genet. 89, 201–218 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  80. O’Shaughnessy, P. J. et al. Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol. 17, e3000002 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  81. Miller, W. L., Fluck, C. E., Breault, D. T. & Feldman, B. J. in Sperling – Pediatric Endocrinology 5th ed (eds Sperling, M. A. et al.) 425–490 (Elsevier, 2021).

  82. Hornig, N. C. & Holterhus, P. M. Molecular basis of androgen insensitivity syndromes. Mol. Cell Endocrinol. 523, 111146 (2021).

    Article  CAS  PubMed  Google Scholar 

  83. Knerr, J. et al. Formin-mediated nuclear actin at androgen receptors promotes transcription. Nature 617, 616–622 (2023).

    Article  CAS  PubMed  Google Scholar 

  84. Boettcher, C. & Fluck, C. E. Rare forms of genetic steroidogenic defects affecting the gonads and adrenals. Best Pract. Res. Clin. Endocrinol. Metab. 36, 101593 (2022).

    Article  CAS  PubMed  Google Scholar 

  85. Pandey, A. V. & Fluck, C. E. NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol. Ther. 138, 229–254 (2013).

    Article  CAS  PubMed  Google Scholar 

  86. Grinspon, R. P., Bergada, I. & Rey, R. A. Male hypogonadism and disorders of sex development. Front. Endocrinol. 11, 211 (2020).

    Article  Google Scholar 

  87. Latronico, A. C. & Arnhold, I. J. Gonadotropin resistance. Endocr. Dev. 24, 25–32 (2013).

    Article  CAS  PubMed  Google Scholar 

  88. Oosterhuis, J. W. & Looijenga, L. H. J. Human germ cell tumours from a developmental perspective. Nat. Rev. Cancer 19, 522–537 (2019).

    Article  CAS  PubMed  Google Scholar 

  89. Stoop, H. et al. Stem cell factor as a novel diagnostic marker for early malignant germ cells. J. Pathol. 216, 43–54 (2008).

    Article  CAS  PubMed  Google Scholar 

  90. Kersemaekers, A. M. et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum. Pathol. 36, 512–521 (2005).

    Article  CAS  PubMed  Google Scholar 

  91. Cools, M., Drop, S. L., Wolffenbuttel, K. P., Oosterhuis, J. W. & Looijenga, L. H. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr. Rev. 27, 468–484 (2006).

    Article  CAS  PubMed  Google Scholar 

  92. Cools, M. et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J. Clin. Endocrinol. Metab. 91, 2404–2413 (2006).

    Article  CAS  PubMed  Google Scholar 

  93. Pyle, L. C. & Nathanson, K. L. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development. Am. J. Med. Genet. C. Semin. Med. Genet. 175, 304–314 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  94. Cools, M. et al. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling. Hum. Reprod. 32, 2561–2573 (2017).

    Article  CAS  PubMed  Google Scholar 

  95. Cools, M. et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J. Clin. Endocrinol. Metab. 90, 5295–5303 (2005).

    Article  CAS  PubMed  Google Scholar 

  96. Humphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M. & Reuter, V. E. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur. Urol. 70, 106–119 (2016).

    Article  PubMed  Google Scholar 

  97. Cools, M. et al. Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J. Clin. Endocrinol. Metab. 96, E1171–E1180 (2011).

    Article  CAS  PubMed  Google Scholar 

  98. Cools, M., Wolffenbuttel, K. P., Drop, S. L., Oosterhuis, J. W. & Looijenga, L. H. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex. Dev. 5, 167–180 (2011).

    Article  CAS  PubMed  Google Scholar 

  99. Oram, S. W., Liu, X. X., Lee, T. L., Chan, W. Y. & Lau, Y. F. TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells. BMC Cancer 6, 154 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  100. Lip, S. Z., Murchison, L. E., Cullis, P. S., Govan, L. & Carachi, R. A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch. Dis. Child. 98, 20–26 (2013).

    Article  PubMed  Google Scholar 

  101. Tack, L. J. W. et al. Management of gonads in adults with androgen insensitivity: an international survey. Horm. Res. Paediatr. 90, 236–246 (2018).

    Article  CAS  PubMed  Google Scholar 

  102. van der Zwan, Y. G., Biermann, K., Wolffenbuttel, K. P., Cools, M. & Looijenga, L. H. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. Eur. Urol. 67, 692–701 (2015).

    Article  PubMed  Google Scholar 

  103. Dorssers, L. C. J. et al. Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development. Br. J. Cancer 120, 444–452 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  104. Nogales, F. F. & Jimenez, R. E. Pathology and Biology of Human Germ Cell Tumors (Springer, 2017).

  105. Audi, L. et al. Genetics in endocrinology: approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST action BM 1303 ‘DSDnet’. Eur. J. Endocrinol. 179, R197–R206 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Kulle, A. et al. Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 ‘DSDnet’. Eur. J. Endocrinol. 176, P1–P9 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Lucas-Herald, A. K., Rodie, M. E. & Ahmed, S. F. Update on the management of a newborn with a suspected difference of sex development. Arch Dis Child. 107, 866–871 (2022).

    Article  PubMed  Google Scholar 

  108. Johannsen, T. H. et al. Peptide hormone analysis in diagnosis and treatment of differences of sex development: joint position paper of EU COST action ‘DSDnet’ and European reference network on rare endocrine conditions. Eur. J. Endocrinol. 182, P1–P15 (2020).

    Article  CAS  PubMed  Google Scholar 

  109. Délot, E. C. & Vilain, E. Towards improved genetic diagnosis of human differences of sex development. Nat. Rev. Genet. 22, 588–602 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  110. Leon, N. Y., Reyes, A. P. & Harley, V. R. A clinical algorithm to diagnose differences of sex development. Lancet Diabetes Endocrinol. 7, 560–574 (2019).

    Article  PubMed  Google Scholar 

  111. Guerrero-Fernandez, J. et al. Management guidelines for disorders / different sex development (DSD) [Spanish]. An. Pediatr. 89, 315.e1–315.e19 (2018).

    Google Scholar 

  112. Fluck, C. E. & Guran, T. Ambiguous genitalia in the newborn. Endotext https://www.ncbi.nlm.nih.gov/books/NBK279168/ (2023).

  113. Prader, A. Genital findings in the female pseudo-hermaphroditism of the congenital adrenogenital syndrome; morphology, frequency, development and heredity of the different genital forms [German]. Helv. Paediatr. Acta 9, 231–248 (1954).

    CAS  PubMed  Google Scholar 

  114. Quigley, C. A. et al. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16, 271–321 (1995).

    CAS  PubMed  Google Scholar 

  115. Ahmed, S. F., Khwaja, O. & Hughes, I. A. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 85, 120–124 (2000).

    Article  CAS  PubMed  Google Scholar 

  116. van der Straaten, S. et al. The external genitalia score (EGS): a European multicenter validation study. J. Clin. Endocrinol. Metab. 105, dgz142 (2020).

    PubMed  Google Scholar 

  117. Sathyanarayana, S. et al. Anogenital distance and penile width measurements in the infant development and the environment study (TIDES): methods and predictors. J. Pediatr. Urol. 11, 76.e1–76.e6 (2015).

    Article  PubMed  Google Scholar 

  118. Thankamony, A., Ong, K. K., Dunger, D. B., Acerini, C. L. & Hughes, I. A. Anogenital distance from birth to 2 years: a population study. Env. Health Perspect. 117, 1786–1790 (2009).

    Article  Google Scholar 

  119. Hryhorczuk, A. L., Phelps, A. S., Yu, R. N. & Chow, J. S. The radiologist’s role in assessing differences of sex development. Pediatr. Radiol. 52, 752–764 (2022).

    Article  PubMed  Google Scholar 

  120. Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  121. Storup, G. Fetal sex determination during ultrasonography: should we focus on how rather than why? Acta Obstet. Gynecol. Scand. 98, 1483–1484 (2019).

    Article  PubMed  Google Scholar 

  122. Lubusky, M., Studnickova, M., Skrivanek, A., Vomackova, K. & Prochazka, M. Ultrasound evaluation of fetal gender at 12-14 weeks. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 156, 324–329 (2012).

    Article  PubMed  Google Scholar 

  123. Guo, N. et al. Positive predictive value of noninvasive prenatal testing for sex chromosome abnormalities. Mol. Biol. Rep. 49, 9251–9256 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Kyriakou, A. et al. Current models of care for disorders of sex development — results from an International survey of specialist centres. Orphanet J. Rare Dis. 11, 155 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  125. Cools, M., Looijenga, L. H., Wolffenbuttel, K. P. & T’Sjoen, G. Managing the risk of germ cell tumourigenesis in disorders of sex development patients. Endocr. Dev. 27, 185–196 (2014).

    Article  PubMed  Google Scholar 

  126. Wolffenbuttel, K. P. et al. Gonadal dysgenesis in disorders of sex development: diagnosis and surgical management. J. Pediatr. Urol. 12, 411–416 (2016).

    Article  CAS  PubMed  Google Scholar 

  127. Dieckmann, K. P. et al. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br. J. Cancer 107, 1754–1760 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Gillis, A. J. et al. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle. Mol. Oncol. 7, 1083–1092 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. van Agthoven, T. & Looijenga, L. H. J. Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test). Oncotarget 8, 58037–58049 (2017).

    Article  PubMed  Google Scholar 

  130. Kalfa, N., Philibert, P., Baskin, L. S. & Sultan, C. Hypospadias: interactions between environment and genetics. Mol. Cell Endocrinol. 335, 89–95 (2011).

    Article  CAS  PubMed  Google Scholar 

  131. Jorgensen, A. et al. Environmental impacts on male reproductive development: lessons from experimental models. Horm. Res. Paediatr. 96, 190–206 (2023).

    Article  CAS  PubMed  Google Scholar 

  132. Hurtado-Gonzalez, P. & Mitchell, R. T. Analgesic use in pregnancy and male reproductive development. Curr. Opin. Endocrinol. Diabetes Obes. 24, 225–232 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Wilkins, L., Jones, H. W. Jr., Holman, G. H. & Stempfel, R. S. Jr Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J. Clin. Endocrinol. Metab. 18, 559–585 (1958).

    Article  CAS  PubMed  Google Scholar 

  134. Troisi, R. et al. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am. J. Obstet. Gynecol. 215, 322 e1–322 e8 (2016).

    Article  PubMed  Google Scholar 

  135. Stillman, R. J. In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am. J. Obstet. Gynecol. 142, 905–921 (1982).

    Article  CAS  PubMed  Google Scholar 

  136. Armstrong, K. et al. We all have a role to play: redressing inequities for children living with CAH and other chronic health conditions of childhood in resource-poor settings. Int. J. Neonatal Screen. 6, 76 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  137. Armstrong, K. L., Henderson, C., Hoan, N. T. & Warne, G. L. Living with congenital adrenal hyperplasia in Vietnam: a survey of parents. J. Pediatr. Endocrinol. Metab. 19, 1207–1223 (2006).

    Article  CAS  PubMed  Google Scholar 

  138. Ediati, A., Maharani, N. & Utari, A. Sociocultural aspects of disorders of sex development. Birth Defects Res. C., Embryo Today 108, 380–383 (2016).

    Article  CAS  PubMed  Google Scholar 

  139. Khan, A. et al. Barriers in access to healthcare services for individuals with disorders of sex differentiation in Bangladesh: an analysis of regional representative cross-sectional data. BMC Public Health 20, 1261 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  140. Joseph, A. A. et al. Gender issues and related social stigma affecting patients with a disorder of sex development in India. Arch. Sex. Behav. 46, 361–367 (2017).

    Article  PubMed  Google Scholar 

  141. Yarhere, I. & Ahmed, S. F. in Practical Pediatric Endocrinology in a Limited Resource Setting (ed. Zacharin, M.) 123–134 (Academic, 2013).

  142. Warne, G. L. & Raza, J. Disorders of sex development (DSDs), their presentation and management in different cultures. Rev. Endocr. Metab. Disord. 9, 227–236 (2008).

    Article  PubMed  Google Scholar 

  143. Utari, A. et al. Challenges in the treatment of late-identified untreated congenital adrenal hyperplasia due to CYP11B1 deficiency: lessons from a developing country. Front. Endocrinol. 13, 1015973 (2022).

    Article  Google Scholar 

  144. Lucas-Herald, A. K., Scougall, K. & Ahmed, S. F. Delivery of multidisciplinary care in the field of differences and disorders of sex development (DSD). Expert Rev. Endocrinol. Metab. 17, 225–234 (2022).

    Article  CAS  PubMed  Google Scholar 

  145. Cools, M. et al. Multi-stakeholder opinion statement on the care of individuals born with differences of sex development: common ground and opportunities for improvement. Horm. Res. Paediatr. 98, 226–242 (2025).

    CAS  PubMed  Google Scholar 

  146. Gardner, M. et al. Decisional support needed when facing tough decisions: survey of parents with children having differences of sex development. Front. Urol. 3, 1089077 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  147. Lightfoot, S. et al. Co-creating a suite of patient decision aids for parents of an infant or young child with differences of sex development: a methods roadmap. Front. Urol. 2, 1020152 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  148. Ernst, M. M., Liao, L. M., Baratz, A. B. & Sandberg, D. E. Disorders of sex development/intersex: gaps in psychosocial care for children. Pediatrics 142, e20174045 (2018).

    Article  PubMed  Google Scholar 

  149. Atlas, G. et al. Challenges in care provision for children and adolescents with differences of sex development. Clin. Endocrinol. 102, 539–546 (2025).

    Article  Google Scholar 

  150. Gramc, M., Streuli, J. & de Clercq, E. Multidisciplinary teams caring for people with variations of sex characteristics: a scoping review. BMJ Paediatr. Open 5, e001257 (2021).

    Article  PubMed Central  Google Scholar 

  151. Bennecke, E. et al. Subjective need for psychological support (PsySupp) in parents of children and adolescents with disorders of sex development (DSD). Eur. J. Pediatr. 174, 1287–1297 (2015).

    Article  PubMed  Google Scholar 

  152. Ernst, M. M. et al. Psychosocial screening in disorders/differences of sex development: psychometric evaluation of the psychosocial assessment tool. Horm. Res. Paediatr. 90, 368–380 (2018).

    Article  CAS  PubMed  Google Scholar 

  153. Sandberg, D. E., Gardner, M., Callens, N. & Mazur, T. DSD-TRN Psychosocial Workgroup, the DSD-TRN Advocacy Advisory Network, and Accord Alliance. Interdisciplinary care in disorders/differences of sex development (DSD): the psychosocial component of the DSD-translational research network. Am. J. Med. Genet. C. Semin. Med. Genet. 175, 279–292 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  154. Mateo-Arriero, I., Perry, Y., Gilbey, D. & Ohan, J. L. Parents’ disclosure of their child’s health and neurodevelopmental conditions: a systematic review and qualitative metasynthesis. J. Fam. Psychol. 39, 503–514 (2025).

    Article  PubMed  Google Scholar 

  155. [No authors listed]. Disclosure of illness status to children and adolescents with HIV infection. American Academy of Pediatrics Committee on Pediatrics AIDS. Pediatrics 103, 164–166 (1999).

    Article  Google Scholar 

  156. Slepian, M. L. The new psychology of secrecy. Curr. Dir. Psychol. Sci. https://doi.org/10.1177/09637214241226676 (2024).

    Article  Google Scholar 

  157. Sisk, B. A., Bluebond-Langner, M., Wiener, L., Mack, J. & Wolfe, J. Prognostic disclosures to children: a historical perspective. Pediatrics 138, e20161278 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  158. Moyer, D. N., Suorsa-Johnson, K. I., Weidler, E. M. & Ernst, M. M. DSD-TRN psychosocial workgroup. Information sharing in differences of sex development: the creation of a caregiver-support tool. Fam. Syst. Health 41, 256–264 (2023).

    Article  PubMed  Google Scholar 

  159. Baratz, A. B., Sharp, M. K., & Sandberg, D. E. in Endocrine Development. Understanding Differences and Disorders of Sex Development (DSD) Endocrine Development (eds Hiort, O. & Ahmed, S.) 99–112 (Karger, 2014).

  160. de Brouwer, I. J., Suijkerbuijk, M., van de Grift, T. C. & Kreukels, B. P. C. First adolescent romantic and sexual experiences in individuals with differences of sex development/intersex conditions. J. Adolesc. Health 71, 688–695 (2022).

    Article  PubMed  Google Scholar 

  161. Mediå, L. M., Sigurdardottir, S., Fauske, L. & Waehre, A. Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study. Int. J. Qual. Stud. Health Well-being 18, 2204635 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  162. Engelen, M. M., Knoll, J. L., Rabsztyn, P. R. I., Maas-van Schaaijk, N. M. & van Gaal, B. G. I. Sexual health communication between healthcare professionals and adolescents with chronic conditions in western countries: an integrative review. Sexuality Disabil. 38, 191–216 (2020).

    Article  Google Scholar 

  163. Bungener, S. L. et al. Talking about sexuality with youth: a taboo in psychiatry? J. Sex. Med. 19, 421–429 (2022).

    Article  PubMed  Google Scholar 

  164. MedlinePlus. NIH https://medlineplus.gov/ (2025).

  165. Orphanet. Orphanet https://www.orpha.net/ (2025).

  166. How sex development works. University Health Network & The Hospital for Sick Children https://pie.med.utoronto.ca/htbw/module.html?module=sex-development (2015).

  167. Intersex-Affirming Hospital Policy Guide: Providing Ethical and Compassionate Health Care to Intersex Patients (Lambda Legal, 2018).

  168. Cools, M. et al. Response to the Council of Europe Human Rights Commissioner’s issue paper on human rights and intersex people. Eur. Urol. 70, 407–409 (2016).

    Article  PubMed  Google Scholar 

  169. Gardner, M. & Sandberg, D. E. Navigating surgical decision making in disorders of sex development (DSD). Front. Pediatr. 6, 339 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  170. Indig, G., Serrano, M., Dalke, K. B., Ejiogu, N. I. & Grimstad, F. Clinician advocacy and intersex health: a history of intersex health care and the role of the clinician advocate past, present, and future. Pediatr. Ann. 50, e359–e365 (2021).

    Article  PubMed  Google Scholar 

  171. “I want to be like nature made me.” Medically Unnecessary Surgeries on Intersex Children in the US (Human Rights Watch & InterACT, 2017).

  172. Légaré, F. & Witteman, H. O. Shared decision making: examining key elements and barriers to adoption into routine clinical practice. Health Aff. 32, 276–284 (2013).

    Article  Google Scholar 

  173. Scalia, P. et al. The impact and utility of encounter patient decision aids: systematic review, meta-analysis and narrative synthesis. Patient Educ. Couns. 102, 817–841 (2019).

    Article  PubMed  Google Scholar 

  174. Niburski, K., Guadagno, E., Mohtashami, S. & Poenaru, D. Shared decision making in surgery: a scoping review of the literature. Health Expect. 23, 1241–1249 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  175. Stacey, D. et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst. Rev. 1, CD001431 (2024).

    PubMed  Google Scholar 

  176. Stacey, D. et al. Are patient decision aids used in clinical practice after rigorous evaluation? A survey of trial authors. Med. Decis. Mak. 39, 805–815 (2019).

    Article  Google Scholar 

  177. Sandberg, D. E. et al. Development of a decision support tool in pediatric differences/disorders of sex development. Semin. Pediatr. Surg. 28, 150838 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  178. Ediati, A. et al. Social stigmatisation in late identified patients with disorders of sex development in Indonesia. BMJ Paediatr. Open 1, e000130 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  179. Kuhnle, U. & Krahl, W. The impact of culture on sex assignment and gender development in intersex patients. Perspect. Biol. Med. 45, 85–103 (2002).

    Article  PubMed  Google Scholar 

  180. Duguid, A. et al. The psychological impact of genital anomalies on the parents of affected children. Acta Paediatr. 96, 348–352 (2007).

    Article  CAS  PubMed  Google Scholar 

  181. Pasterski, V., Mastroyannopoulou, K., Wright, D., Zucker, K. J. & Hughes, I. A. Predictors of posttraumatic stress in parents of children diagnosed with a disorder of sex development. Arch. Sex. Behav. 43, 369–375 (2014).

    Article  PubMed  Google Scholar 

  182. Traino, K. A. et al. Stigma, intrusiveness, and distress in parents of children with a disorder/difference of sex development. J. Dev. Behav. Pediatr. 43, e473–e482 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  183. Weidler, E. M. & Peterson, K. E. The impact of culture on disclosure in differences of sex development. Semin. Pediatr. Surg. 28, 150840 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  184. Auer, M. K., Nordenstrom, A., Lajic, S. & Reisch, N. Congenital adrenal hyperplasia. Lancet 401, 227–244 (2023).

    Article  CAS  PubMed  Google Scholar 

  185. Stancampiano, M. R. et al. Congenital micropenis: etiology and management. J. Endocr. Soc. 6, bvab172 (2022).

    Article  PubMed  Google Scholar 

  186. Fu, X. H., Zhang, W. Q. & Qu, X. S. Correlation of androgen receptor and SRD5A2 gene mutations with pediatric hypospadias in 46, XY DSD children. Genet. Mol. Res. 15, 15018232 (2016).

    Article  CAS  PubMed  Google Scholar 

  187. Nordenstrom, A. et al. Pubertal induction and transition to adult sex hormone replacement in patients with congenital pituitary or gonadal reproductive hormone deficiency: an Endo-ERN clinical practice guideline. Eur. J. Endocrinol. 186, G9–G49 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  188. Andrade, J. G. R. et al. Clinical findings and follow-up of 46,XY and 45,X/46,XY testicular dysgenesis. Sex. Dev. 13, 171–177 (2019).

    Article  CAS  PubMed  Google Scholar 

  189. Ljubicic, M. L. et al. Clinical but not histological outcomes in males with 45,X/46,XY mosaicism vary depending on reason for diagnosis. J. Clin. Endocrinol. Metab. 104, 4366–4381 (2019).

    Article  PubMed  Google Scholar 

  190. Tantawy, S. et al. Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations. Eur. J. Endocrinol. 167, 125–130 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  191. Chang, S., Skakkebaek, A., Davis, S. M. & Gravholt, C. H. Morbidity in Klinefelter syndrome and the effect of testosterone treatment. Am. J. Med. Genet. C Semin. Med. Genet. 184, 344–355 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  192. Vorona, E., Zitzmann, M., Gromoll, J., Schuring, A. N. & Nieschlag, E. Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J. Clin. Endocrinol. Metab. 92, 3458–3465 (2007).

    Article  CAS  PubMed  Google Scholar 

  193. Lek, N. et al. Predicting puberty in partial androgen insensitivity syndrome: use of clinical and functional androgen receptor indices. eBioMedicine 36, 401–409 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  194. Hughes, I. A. et al. Androgen insensitivity syndrome. Lancet 380, 1419–1428 (2012).

    Article  CAS  PubMed  Google Scholar 

  195. Kim, Y. M., Oh, A., Kim, K. S., Yoo, H. W. & Choi, J. H. Pubertal outcomes and sex of rearing of patients with ovotesticular disorder of sex development and mixed gonadal dysgenesis. Ann. Pediatr. Endocrinol. Metab. 24, 231–236 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  196. Bernard, V. et al. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum. Reprod. 31, 782–788 (2016).

    Article  PubMed  Google Scholar 

  197. Stancampiano, M. R. et al. Testosterone therapy and its monitoring in adolescent boys with hypogonadism: results of an international survey from the I-DSD registry. Sex. Dev. 15, 236–243 (2021).

    Article  CAS  PubMed  Google Scholar 

  198. Gawlik, A. M. et al. Late-onset puberty induction by transdermal estrogen in Turner syndrome girls — a longitudinal study. Front. Endocrinol. 9, 23 (2018).

    Article  Google Scholar 

  199. Lawrence, S. E., Faught, K. A., Vethamuthu, J. & Lawson, M. L. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J. Pediatr. 145, 71–76 (2004).

    Article  CAS  PubMed  Google Scholar 

  200. Saito, R. et al. Tamoxifen treatment for pubertal gynecomastia in two siblings with partial androgen insensitivity syndrome. Horm. Res. Paediatr. 81, 211–216 (2014).

    Article  CAS  PubMed  Google Scholar 

  201. Patjamontri, S. et al. Gynecomastia and its management in boys with partial androgen insensitivity syndrome. J. Clin. Endocrinol. Metab. 110, e2018–e2025 (2025).

    Article  CAS  PubMed  Google Scholar 

  202. Almasri, J. et al. Genital reconstructive surgery in females with congenital adrenal hyperplasia: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 103, 4089–4096 (2018).

    Article  PubMed  Google Scholar 

  203. Baskin, A. et al. Post-operative complications following feminizing genitoplasty in moderate to severe genital atypia: results from a multicenter, observational prospective cohort study. J. Pediatr. Urol. 16, 568–575 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  204. Dangle, P. P., Lee, A., Chaudhry, R. & Schneck, F. X. Surgical complications following early genitourinary reconstructive surgery for congenital adrenal hyperplasia-interim analysis at 6 years. Urology 101, 111–115 (2017).

    Article  PubMed  Google Scholar 

  205. Nordenstrom, A. et al. Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients’ perception. J. Clin. Endocrinol. Metab. 95, 3633–3640 (2010).

    Article  PubMed  Google Scholar 

  206. Rapp, M. et al. Self- and proxy-reported outcomes after surgery in people with disorders/differences of sex development (DSD) in Europe (dsd-LIFE). J. Pediatr. Urol. 17, 353–365 (2021).

    Article  PubMed  Google Scholar 

  207. Stites, J., Bernabe, K. J., Galan, D., Felsen, D. & Poppas, D. P. Urinary continence outcomes following vaginoplasty in patients with congenital adrenal hyperplasia. J. Pediatr. Urol. 13, 38.e1–e7 (2017).

    Article  PubMed  Google Scholar 

  208. Krege, S. et al. Long-term results of surgical treatment and patient-reported outcomes in congenital adrenal hyperplasia — a multicenter European registry study. J. Clin. Med. 11, 4629 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  209. Meyer-Bahlburg, H. F. L. The timing of genital surgery in somatic intersexuality: surveys of patients’ preferences. Horm. Res. Paediatr. 95, 12–20 (2022).

    Article  CAS  PubMed  Google Scholar 

  210. Cools, M., Verhagen, E., Hoebeke, P., Van Hoecke, E. & Cannoot, P. Working towards convergence of the clinical management of differences of sex development/intersex conditions and the human rights framework: a case study. Clin. Endocrinol. 101, 499–506 (2024).

    Article  Google Scholar 

  211. Sandberg, D. E. & Vilain, E. Decision making in differences of sex development/intersex care in the USA: bridging advocacy and family-centred care. Lancet Diabetes Endocrinol. 10, 381–383 (2022).

    Article  PubMed  Google Scholar 

  212. Crouch, N. S., Minto, C. L., Laio, L. M., Woodhouse, C. R. & Creighton, S. M. Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: a pilot study. BJU Int. 93, 135–138 (2004).

    Article  CAS  PubMed  Google Scholar 

  213. Minto, C. L., Liao, L. M., Woodhouse, C. R., Ransley, P. G. & Creighton, S. M. The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study. Lancet 361, 1252–1257 (2003).

    Article  PubMed  Google Scholar 

  214. Poppas, D. P. et al. Nerve sparing ventral clitoroplasty preserves dorsal nerves in congenital adrenal hyperplasia. J. Urol. 178, 1802–1806 (2007).

    Article  PubMed  Google Scholar 

  215. Rink, R. C. et al. Reconstruction of the high urogenital sinus: early perineal prone approach without division of the rectum. J. Urol. 158, 1293–1297 (1997).

    Article  CAS  PubMed  Google Scholar 

  216. Salle, J. L. et al. Surgical treatment of high urogenital sinuses using the anterior sagittal transrectal approach: a useful strategy to optimize exposure and outcomes. J. Urol. 187, 1024–1031 (2012).

    Article  PubMed  Google Scholar 

  217. Bangalore Krishna, K. et al. Individualized care for patients with intersex (differences of sex development): part 4/4. Considering the ifs, whens, and whats regarding sexual-reproductive system surgery. J. Pediatr. Urol. 17, 338–345 (2021).

    Article  PubMed  Google Scholar 

  218. Money, J. Ablatio penis: normal male infant sex-reassigned as a girl. Arch. Sex. Behav. 4, 65–71 (1975).

    Article  CAS  PubMed  Google Scholar 

  219. Johnson, E. K., Whitehead, J. & Cheng, E. Y. Differences of sex development: current issues and controversies. Urol. Clin. North Am. 50, 433–446 (2023).

    Article  PubMed  Google Scholar 

  220. Baskin, L. S. et al. Anatomical studies of the human clitoris. J. Urol. 162, 1015–1020 (1999).

    Article  CAS  PubMed  Google Scholar 

  221. Pena, A., Levitt, M. A., Hong, A. & Midulla, P. Surgical management of cloacal malformations: a review of 339 patients. J. Pediatr. Surg. 39, 470–479 (2004).

    Article  PubMed  Google Scholar 

  222. Rink, R. C. et al. Partial urogenital mobilization: a limited proximal dissection. J. Pediatr. Urol. 2, 351–356 (2006).

    Article  CAS  PubMed  Google Scholar 

  223. Gong, E. M. & Cheng, E. Y. Current challenges with proximal hypospadias: we have a long way to go. J. Pediatr. Urol. 13, 457–467 (2017).

    Article  PubMed  Google Scholar 

  224. Long, C. J. et al. Post-operative complications following masculinizing genitoplasty in moderate to severe genital atypia: results from a multicenter, observational prospective cohort study. J. Pediatr. Urol. 17, 379–386 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  225. Long, C. J. et al. Intermediate-term followup of proximal hypospadias repair reveals high complication rate. J. Urol. 197, 852–858 (2017).

    Article  PubMed  Google Scholar 

  226. McNamara, E. R. et al. Management of proximal hypospadias with 2-stage repair: 20-year experience. J. Urol. 194, 1080–1085 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  227. Saltzman, A. F. et al. Patients with disorders of sex development and proximal hypospadias are at high risk for reoperation. World J. Urol. 36, 2051–2058 (2018).

    Article  PubMed  Google Scholar 

  228. Johal, N. S., Nitkunan, T., O’Malley, K. & Cuckow, P. M. The two-stage repair for severe primary hypospadias. Eur. Urol. 50, 366–371 (2006).

    Article  PubMed  Google Scholar 

  229. Husmann, D. A. Erectile dysfunction in patients undergoing multiple attempts at hypospadias repair: etiologies and concerns. J. Pediatr. Urol. 17, 166 e1–e7 (2021).

    Article  PubMed  Google Scholar 

  230. Cheng, L. et al. Testicular cancer. Nat. Rev. Dis. Primers 4, 29 (2018).

    Article  PubMed  Google Scholar 

  231. van de Grift, T. C.; dsd-LIFE.Condition openness is associated with better mental health in individuals with an intersex/differences of sex development condition: structural equation modeling of European multicenter data. Psychol. Med. 53, 2229–2240 (2023).

    Article  PubMed  Google Scholar 

  232. Berra, M., Liao, L. M., Creighton, S. M. & Conway, G. S. Long-term health issues of women with XY karyotype. Maturitas 65, 172–178 (2010).

    Article  PubMed  Google Scholar 

  233. Dati, E. et al. Body composition and metabolic profile in women with complete androgen insensitivity syndrome. Sex. Dev. 3, 188–193 (2009).

    Article  CAS  PubMed  Google Scholar 

  234. Bertelloni, S., Meriggiola, M. C., Dati, E., Balsamo, A. & Baroncelli, G. I. Bone mineral density in women living with complete androgen insensitivity syndrome and intact testes or removed gonads. Sex. Dev. 11, 182–189 (2017).

    Article  CAS  PubMed  Google Scholar 

  235. Bojesen, A., Juul, S., Birkebaek, N. H. & Gravholt, C. H. Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J. Clin. Endocrinol. Metab. 91, 1254–1260 (2006).

    Article  CAS  PubMed  Google Scholar 

  236. Bojesen, A. et al. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos. Int. 22, 1441–1450 (2011).

    Article  CAS  PubMed  Google Scholar 

  237. Ferlin, A. et al. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism. J. Clin. Endocrinol. Metab. 96, E739–E745 (2011).

    Article  CAS  PubMed  Google Scholar 

  238. Vena, W. et al. Prevalence and determinants of radiological vertebral fractures in patients with Klinefelter syndrome. Andrology 8, 1699–1704 (2020).

    Article  CAS  PubMed  Google Scholar 

  239. Batista, R. L. et al. Sexuality and fertility desire in a large cohort of individuals with 46, XY differences in sex development. Clinics 78, 100185 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  240. Kreukels, B. P. C. et al. Gender dysphoria and gender change in disorders of sex development/intersex conditions: results from the dsd-LIFE study. J. Sex. Med. 15, 777–785 (2018).

    Article  PubMed  Google Scholar 

  241. Loch Batista, R. et al. Psychosexual aspects, effects of prenatal androgen exposure, and gender change in 46,XY disorders of sex development. J. Clin. Endocrinol. Metab. 104, 1160–1170 (2019).

    Article  PubMed  Google Scholar 

  242. Wisniewski, A. B. et al. Management of 46,XY differences/disorders of sex development (DSD) throughout life. Endocr. Rev. 40, 1547–1572 (2019).

    Article  PubMed  Google Scholar 

  243. Gomes, N. L. et al. Long-term outcomes and molecular analysis of a large cohort of patients with 46,XY disorder of sex development due to partial gonadal dysgenesis. Clin. Endocrinol. 89, 164–177 (2018).

    Article  CAS  Google Scholar 

  244. Callens, N. et al. Recalled and current gender role behavior, gender identity and sexual orientation in adults with disorders/differences of sex development. Horm. Behav. 86, 8–20 (2016).

    Article  PubMed  Google Scholar 

  245. Slowikowska-Hilczer, J. et al. Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: findings from the dsd-LIFE study. Fertil. Steril. 108, 822–831 (2017).

    Article  PubMed  Google Scholar 

  246. Juul, A., Gravholt, C. H., De Vos, M., Koledova, E. & Cools, M. Individuals with numerical and structural variations of sex chromosomes: interdisciplinary management with focus on fertility potential. Front. Endocrinol. 14, 1160884 (2023).

    Article  Google Scholar 

  247. Giwercman, A. et al. Preserved male fertility despite decreased androgen sensitivity caused by a mutation in the ligand-binding domain of the androgen receptor gene. J. Clin. Endocrinol. Metab. 85, 2253–2259 (2000).

    CAS  PubMed  Google Scholar 

  248. Islam, R. et al. Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development. Clin. Endocrinol. 91, 237–244 (2019).

    Article  Google Scholar 

  249. Tordjman, K. M. et al. Fertility after high-dose testosterone and intracytoplasmic sperm injection in a patient with androgen insensitivity syndrome with a previously unreported androgen receptor mutation. Andrologia 46, 703–706 (2014).

    Article  CAS  PubMed  Google Scholar 

  250. Brännström, M., Bokström, H., Hagberg, H. & Carlsson, Y. Maternal and perinatal outcomes of live births after uterus transplantation: a systematic review. Acta Obstet. Gynecol. Scand. 104, 559–578 (2025).

    Article  PubMed  Google Scholar 

  251. Johannesson, L. et al. The first 5 years of uterus transplant in the US: a report from the United States uterus transplant consortium. JAMA Surg. 157, 790–797 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  252. Rapp, M. et al. Multicentre cross-sectional clinical evaluation study about quality of life in adults with disorders/differences of sex development (DSD) compared to country specific reference populations (dsd-LIFE). Health Qual. Life Outcomes 16, 54 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  253. Thyen, U. et al. Quality of health care in adolescents and adults with disorders/differences of sex development (DSD) in six European countries (dsd-LIFE). BMC Health Serv. Res. 18, 527 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  254. Erens, B. et al. Nonprobability web surveys to measure sexual behaviors and attitudes in the general population: a comparison with a probability sample interview survey. J. Med. Internet Res. 16, e276 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  255. Hines, M. Brain Gender (Oxford Univ. Press, 2004).

  256. Hines, M. in Hormones, Brain and Behavior (ed. Pfaff, D. W.) 425–461 (Academic, 2002).

  257. Berenbaum, S. A., Korman, K. & Leveroni, C. Early hormones and sex differences in cognitive abilities. Learn. Individ. Differ. 7, 303–321 (1995).

    Article  Google Scholar 

  258. Chase, C. What is the agenda of the intersex patient advocacy movement? Endocrinologist 13, 240–242 (2003).

    Article  Google Scholar 

  259. Lee, P. A., Houk, C. P., Ahmed, S. F. & Hughes, I. A.; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 118, e488–500 (2006).

    Article  PubMed  Google Scholar 

  260. Engberg, H. et al. Increased psychiatric morbidity in women with complete androgen insensitivity syndrome or complete gonadal dysgenesis. J. Psychosom. Res. 101, 122–127 (2017).

    Article  PubMed  Google Scholar 

  261. Sorouri Khorashad, B. et al. Psychiatric comorbidities in women with complete androgen insensitivity syndrome or mullerian aplasia/agenesis. J. Clin. Endocrinol. Metab. 110, 1906–1914 (2025).

    Article  CAS  PubMed  Google Scholar 

  262. Liedmeier, A. et al. The influence of psychosocial and sexual wellbeing on quality of life in women with differences of sexual development. Compr. Psychoneuroendocrinol. 8, 100087 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  263. Ellerkamp, V. et al. Surgical therapy after failed feminizing genitoplasty in young adults with disorders of sex development: retrospective analysis and review of the literature. J. Sex. Med. 18, 1797–1806 (2021).

    Article  PubMed  Google Scholar 

  264. van de Grift, T. C., Rapp, M., Holmdahl, G., Duranteau, L. & Nordenskjold, A.; on behalf of the dsd-LIFE group.Masculinizing surgery in disorders/differences of sex development: clinician- and participant-evaluated appearance and function. BJU Int. 129, 394–405 (2022).

    Article  PubMed  Google Scholar 

  265. Sandberg D. E., Mazur T. in Gender Dysphoria and Disorders of Sex Development. Focus on Sexuality Research (eds Kreukels, B. P. C. et al.) 93–114 (Springer Science+Business Media; 2014).

  266. Traino, K. A. et al. Adverse birth experiences and parent adjustment associated with atypical genital appearance due to differences of sex development. J. Pediatr. Psychol. 48, 759–767 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  267. Boucher, N. A., Alkazemi, M. H., Tejwani, R. & Routh, J. C. Parents of children with newly diagnosed disorders of sex development identify major concerns: a qualitative study. Urology 164, 218–223 (2022).

    Article  PubMed  Google Scholar 

  268. Verma, P. et al. Evaluation of a nurse-led counselling intervention on selected outcome variables for parents of children with congenital adrenal hyperplasia. J. Pediatr. Endocrinol. Metab. 36, 248–254 (2023).

    Article  PubMed  Google Scholar 

  269. Nordenström, A. et al. Hormone therapy and patient satisfaction with treatment, in a large cohort of diverse disorders of sex development. Clin. Endocrinol. 88, 397–408 (2018).

    Article  Google Scholar 

  270. Cheng, J. W. et al. Integration of child life services in the delivery of multi-disciplinary differences in sexual development (DSD) and congenital adrenal hyperplasia (CAH) care. J. Pediatr. Urol. 18, 612.e1–e6 (2022).

    Article  PubMed  Google Scholar 

  271. Dwiggins, M. et al. Multidimensional aspects of female sexual function in congenital adrenal hyperplasia: a case-control study. J. Endocr. Soc. 4, bvaa131 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  272. Szymanski, K. M. et al. Growing up with clitoromegaly: experiences of North American women with congenital adrenal hyperplasia. J. Pediatr. Urol. 18, 775–783 (2022).

    Article  PubMed  Google Scholar 

  273. Weijenborg, P. T. M., Kluivers, K. B., Dessens, A. B., Kate-Booij, M. J. & Both, S. Sexual functioning, sexual esteem, genital self-image and psychological and relational functioning in women with Mayer-Rokitansky-Kuster-Hauser syndrome: a case-control study. Hum. Reprod. 34, 1661–1673 (2019).

    Article  CAS  PubMed  Google Scholar 

  274. Nowotny, H. F. & Reisch, N. Challenges waiting for an adult with DSD. Horm. Res. Paediatr. 96, 207–221 (2023).

    Article  CAS  PubMed  Google Scholar 

  275. Chulani, V. L., Gomez-Lobo, V., Kielb, S. J. & Grimsby, G. M. Healthcare transition for patients with differences of sexual development and complex urogenital conditions. Semin. Pediatr. Surg. 28, 150846 (2019).

    Article  PubMed  Google Scholar 

  276. Auchus, R. J. & Quint, E. H. Adolescents with disorders of sex development (DSD)-lost in transition? Horm. Metab. Res. 47, 367–374 (2015).

    Article  CAS  PubMed  Google Scholar 

  277. Crouch, N. S. & Creighton, S. M. Transition of care for adolescents with disorders of sex development. Nat. Rev. Endocrinol. 10, 436–442 (2014).

    Article  PubMed  Google Scholar 

  278. Mediå, L. M. et al. ‘It was supposed to be a secret’: a study of disclosure and stigma as experienced by adults with differences of sex development. Health Psychol. Behav. Med. 10, 579–595 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  279. Meyer-Bahlburg, H. F., Reyes-Portillo, J. A., Khuri, J., Ehrhardt, A. A. & New, M. I. Syndrome-related stigma in the general social environment as reported by women with classical congenital adrenal hyperplasia. Arch. Sex. Behav. 46, 341–351 (2017).

    Article  PubMed  Google Scholar 

  280. Meyer-Bahlburg, H. F. L., Khuri, J., Reyes-Portillo, J., Ehrhardt, A. A. & New, M. I. Stigma associated with classical congenital adrenal hyperplasia in women’s sexual lives. Arch. Sex. Behav. 47, 943–951 (2018).

    Article  PubMed  Google Scholar 

  281. Meyer-Bahlburg, H. F. L., Khuri, J., Reyes-Portillo, J. & New, M. I. Stigma in medical settings as reported retrospectively by women with congenital adrenal hyperplasia (CAH) for their childhood and adolescence. J. Pediatr. Psychol. 42, 496–503 (2017).

    PubMed  Google Scholar 

  282. Logie, C. H. & Nyblade, L. Recognizing and responding to stigma-related barriers in health care. Nat. Rev. Dis. Primers 10, 70 (2024).

    Article  PubMed  Google Scholar 

  283. Hiort, O. et al. Addressing gaps in care of people with conditions affecting sex development and maturation. Nat. Rev. Endocrinol. 15, 615–622 (2019).

    Article  PubMed  Google Scholar 

  284. Lucas-Herald, A. K. et al. I-DSD: the first 10 years. Horm. Res. Paediatr. 96, 238–246 (2023).

    Article  CAS  PubMed  Google Scholar 

  285. Sanders, C. et al. Involving individuals with disorders of sex development and their parents in exploring new models of shared learning: proceedings from a DSDnet COST action workshop. Sex. Dev. 12, 225–231 (2018).

    Article  PubMed  Google Scholar 

  286. World Health Organization. WHO Framework for Meaningful Engagement of People Living with Noncommunicable Diseases, and Mental Health and Neurological Conditions (WHO, 2023).

  287. Syryn, H., De Baere, E. & Cools, M. Approach to the patient with a difference of sex development. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/clinem/dgaf386 (2025).

Download references

Acknowledgements

C.E.F. acknowledges the support by Swiss National Science Foundation grant 320030_197725. The authors thank Melissa D. Gardner for supporting manuscript editing.

Author information

Authors and Affiliations

Authors

Contributions

Introduction (S.F.A.); Epidemiology (S.F.A.); Mechanisms/pathophysiology (M.C., V.H. and R.R.); Diagnosis, screening and prevention (M.C. and C.E.F.); Management (E.Y.C., B.B.M., A.N. and D.E.S.); Quality of life (D.E.S., K.A. and A.U.); Outlook (S.F.A., K.A., A.U. and C.E.F.); overview of the Primer (S.F.A. and C.E.F.).

Corresponding author

Correspondence to Christa E. Flück.

Ethics declarations

Competing interests

Authors declare no competing interests.

Peer review

Peer review information

Nature Reviews Disease Primers thanks O. Hiort, M. Fukami and the other, anonymous reviewer(s) for their contribution to the peer review of this work.

Additional information

Informed consent

The authors affirm that patient participants provided informed consent for publication of their experiences.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Glossary

Adrenoleukodystrophy

Rare X-linked recessive inherited disorder, characterized by neurological symptoms and dysfunctional adrenal glands.

Androgen insensitivity syndrome

Differences of sex development condition characterized by decreased or absent androgen signalling due to a genetic defect affecting the binding of testosterone or dihydrotestosterone to the androgen receptor.

Bipotential gonads

Undifferentiated gonads that have the capacity to develop into either ovaries or testes.

Chordee

A congenital condition that affects penile function and appearance, causing a curvature in the penis during erection.

Cryptorchidism

Failure of testes to descend into the scrotum.

Dysgerminoma

Malignant tumour arising from primordial germ cells in the ovary or dysgenetic gonad.

Gender identity

A person’s basic subjective sense of self as a male, as a female or some other gendered identity, for example, an ‘intersex’ identity. Gender identity develops over time and is not directly a function of genes or prenatal sex hormone exposure.

Gender role

Behaviours, attitudes and personality traits that a society, in a given culture and historical period, designates as masculine or feminine, and that are more ‘appropriate’ to or typical of the male or female social role.

Gonadal dysgenesis

Differences of sex development condition characterized by the loss of primordial germ cells and abnormal gonadal development during embryonic development.

Granulosa cells

Female-supporting cell lineage in the ovary.

Klinefelter syndrome

A condition affecting only males that occurs when an extra X chromosome is present (47,XXY).

Labioscrotal folds

A paired structure that is present during the indifferent stage of external genitalia development and is responsible for the formation of the labia majora in females and the scrotum in males.

Leydig cells

Steroid-producing cells in the testis.

Minifascicular peripheral neuropathy

A rare autosomal recessive inherited condition characterized by the presence of small fascicles in the peripheral nervous system.

Non-seminoma

Malignant tumour derived from seminoma or its precursor lesion through reprogramming of the seminomatous cells into an embryonal carcinoma cell.

Sertoli cells

Male-supporting cell lineage in the testis.

Turner syndrome

A condition affecting only females that occurs when one of the X chromosomes (sex chromosomes) is missing or partially missing.

Urethrovaginal fistula

A condition characterized by urine leakage from the urethra into the vagina due to an abnormal connection between the urethra and the vagina.

Vaginal stenosis

An abnormal narrowing of the vaginal canal.

Virilization

A condition in which females develop exaggerated male traits such as excessive facial hair.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, S.F., Armstrong, K., Cheng, E.Y. et al. Differences of sex development. Nat Rev Dis Primers 11, 54 (2025). https://doi.org/10.1038/s41572-025-00637-y

Download citation

  • Accepted:

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41572-025-00637-y

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing